ISOPAQUE CYSTO 100 MG Ireland - English - HPRA (Health Products Regulatory Authority)

isopaque cysto 100 mg

nycomed (uk) limited - sodium metrizoate calcium metrizoate magnesium metrizoate meglumine metrizoate - i millilitre

VISIPAQUE iodixanol 97.8g/150mL (652mg/mL) injection bottle Australia - English - Department of Health (Therapeutic Goods Administration)

visipaque iodixanol 97.8g/150ml (652mg/ml) injection bottle

ge healthcare australia pty ltd - iodixanol, quantity: 652 mg/ml - injection, solution - excipient ingredients: water for injections; sodium calcium edetate; trometamol; calcium chloride dihydrate; sodium hydroxide; sodium chloride; hydrochloric acid - visipaque is indicated, in adult patients, for angiocardiography, peripheral arteriography, visceral arteriography, cerebral arteriography, contrast-enhanced computed tomography of the head and body, excretory urography and venography. in arteriography, visipaque may be used for both conventional radiography and digital subtraction angiography (dsa).

VISIPAQUE iodixanol 13.0g/20mL (652mg/mL) injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

visipaque iodixanol 13.0g/20ml (652mg/ml) injection ampoule

ge healthcare australia pty ltd - iodixanol, quantity: 652 mg/ml - injection, solution - excipient ingredients: water for injections; sodium calcium edetate; trometamol; calcium chloride dihydrate; sodium hydroxide; sodium chloride; hydrochloric acid - this medicinal product is for diagnostic use only. visipaque is indicated in adult patients for angiocardiography, peripheral arteriography, visceral arteriography, cerebral arteriography, contrast-enhanced computed tomography of the head and body, excretory urography and venography. in arteriography, visipaque may be used for both conventional radiography and digital subtraction angiography (dsa). in children, visipaque is indicated for cardioangiography, urography, ct enhancement and studies of the upper gastrointestinal tract.

VISIPAQUE iodixanol 11.0g/20mL (550mg/mL) injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

visipaque iodixanol 11.0g/20ml (550mg/ml) injection vial

ge healthcare australia pty ltd - iodixanol, quantity: 550 mg/ml - injection, solution - excipient ingredients: sodium calcium edetate; calcium chloride dihydrate; trometamol; water for injections; sodium chloride; sodium hydroxide; hydrochloric acid - this medicinal product is for diagnostic use only. visipaque is indicated in adult patients for angiocardiography, peripheral arteriography, visceral arteriography, cerebral arteriography, contrast-enhanced computed tomography of the head and body, excretory urography and venography. in arteriography, visipaque may be used for both conventional radiography and digital subtraction angiography (dsa). in children, visipaque is indicated for cardioangiography, urography, ct enhancement and studies of the upper gastrointestinal tract.